Antibody titers against SARS-CoV-2 decline, but do not disappear for several months

BACKGROUND: To develop an effective vaccine against a novel viral pathogen, it is important to understand the longitudinal antibody responses against its first infection. Here we performed a longitudinal study of antibody responses against SARS-CoV-2 in symptomatic patients. METHODS: Sequential bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamayoshi, Seiya, Yasuhara, Atsuhiro, Ito, Mutsumi, Akasaka, Osamu, Nakamura, Morio, Nakachi, Ichiro, Koga, Michiko, Mitamura, Keiko, Yagi, Kazuma, Maeda, Kenji, Kato, Hideaki, Nojima, Masanori, Pattinson, David, Ogura, Takayuki, Baba, Rie, Fujita, Kensuke, Nagai, Hiroyuki, Yamamoto, Shinya, Saito, Makoto, Adachi, Eisuke, Ochi, Junichi, Hattori, Shin-ichiro, Suzuki, Tetsuya, Miyazato, Yusuke, Chiba, Shiho, Okuda, Moe, Murakami, Jurika, Hamabata, Taiki, Iwatsuki-Horimoto, Kiyoko, Nakajima, Hideaki, Mitsuya, Hiroaki, Omagari, Norio, Sugaya, Norio, Yotsuyanagi, Hiroshi, Kawaoka, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877219/
https://www.ncbi.nlm.nih.gov/pubmed/33589882
http://dx.doi.org/10.1016/j.eclinm.2021.100734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877219/
https://www.ncbi.nlm.nih.gov/pubmed/33589882
http://dx.doi.org/10.1016/j.eclinm.2021.100734

Ejemplares similares